Parecoxib for pain after bleeding stroke study
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a pain medicine called parecoxib (injected into a vein) for people who have had a bleeding stroke around the brain (subarachnoid hemorrhage). It aims to see if it helps with pain without causing serious side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You weigh more than 110 pounds (50 kg)
- You were diagnosed with a spontaneous bleed around the brain (subarachnoid hemorrhage) within the last 48 hours
- You are not pregnant, breastfeeding, or planning to become pregnant
- You are not taking certain other pain relievers or steroids
- You do not have severe liver disease, active stomach ulcers, or certain heart conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether celecoxib (an anti-inflammatory medicine) can improve outcomes after an intracerebral hemorrhage (a type of stroke caused by bleeding in the brain). It also studies how the medicine may help the body recover. You would need to start treatment quickly after symptoms begin and meet several safety and bleeding-control requirements.
This trial tests whether the drug ticagrelor, which helps prevent blood clots, can reduce the risk of a stroke occurring days after a mild form of bleeding in the brain. It is given as an add-on to the standard treatment for the bleeding aneurysm.
This study tests two blood-thinning medicines (sarpogrelate and clopidogrel) to see which one improves leg blood flow and reduces leg pain in people who have had a stroke and also have blocked leg arteries.
This trial tests whether adding a drug called cilostazol to standard care (nimodipine) helps people recover better after a type of stroke caused by a bleeding brain aneurysm. It may help prevent complications like narrowing of blood vessels in the brain.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This study tests a blood-thinning medicine called tirofiban to see if it helps reduce delayed brain damage after a type of stroke from a bleeding brain aneurysm. It is for people who have already had their aneurysm fixed with coiling, and the medicine is given soon after.
Hear when a new Neurological Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.